Opiant Pharmaceuticals, Inc. (OPNT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

12.64

+0.44

(+3.61%)

At close: 04:00PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Fast Stochastic

View all chart patterns

Performance Outlook

Previous Close	12.20
Open	12.59
Bid	7.50 x 1100
Ask	19.52 x 1200
Day's Range	11.92 - 12.81
52 Week Range	7.34 - 37.71
Volume	14,688
Avg. Volume	92,804

Market Cap	64.3M
Beta (5Y Monthly)	0.67
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

75% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for OPNT

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Opiant Pharmaceuticals, Inc.
AMPH: Raising target price to $35.00AMPHASTAR PHARMACEUTICALS IN has an Investment Rating of BUY; a target price of $35.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.
Rating
Fair Value
Economic Moat
4 days agoArgus Research